Cancer
A New Approach for Men Whose Cancer Returns Prostate cancer is one of the most common cancers among men. Many patients respond well to initial treatments like surgery or radiation, but some later experience a rise in prostate-specific antigen (PSA) levels which is an early sign that the cancer may
2025 Approvals
What is it prescribed for? HERNEXEOS is used in adults with advanced or metastatic non-small cell lung cancer (NSCLC) that has a HER2 mutation and has already been treated with another systemic therapy. What is the name of the drug and what does it do? The medicine is HERNEXEOS® (zongertinib)
Cancer
Endometrial cancer—also known as uterine cancer—is one of the most common cancers in women. Cases are rising around the world, but survival is improving thanks to early detection and modern treatments. In this video, we break down a 2024 review published in Cancers by Baker-Rand and Kitson.
Cancer
Endometrial cancer (cancer of the lining of the uterus) is one of the most common cancers in women worldwide. Cases are rising, partly due to aging populations, obesity, and diabetes. But new advances in prevention, diagnosis, and treatment are offering hope. What is Endometrial Cancer and Why Is It Rising?
Cancer
Breast cancer is not all the same. Some types are harder to treat than others. One of the toughest forms is called triple-negative breast cancer. A new medicine, sacituzumab govitecan, offers hope for patients whose cancer has spread and stopped responding to other treatments. What is Triple-Negative Breast Cancer? Triple-negative
Cancer
What Did the Research Discover? This study examined racial and ethnic disparities in the use of novel hormonal therapy (NHT) agents for advanced prostate cancer using Surveillance, Epidemiology, and End Results (SEER)–Medicare linked data from 2011 to 2017. The study analyzed 3,748 men with advanced prostate cancer, including
Cancer
Can starting immunotherapy before surgery change the future of stomach and esophageal cancer treatment? A 2024 study called the PANDA trial, published in Nature Medicine, tested this very idea—and the early results are promising. Researchers found that combining immunotherapy with chemotherapy befor
Cancer
What Did the Research Discover? Researchers investigated whether common blood tests could help identify hidden cancers in patients experiencing abdominal pain or bloating. Diagnosing cancer in people with these nonspecific symptoms is challenging, and while blood tests are commonly used in primary care, their effectiveness in predicting cancer risk was
Cancer
What Did the Research Discover? Researchers studied whether women with hormone receptor-positive early breast cancer could safely pause their endocrine therapy to try to get pregnant. This treatment is usually taken for 5 to 10 years to lower the risk of cancer coming back, but pregnancy is not recommended during
Cancer
What Did the Research Discover? This study examined whether adding pembrolizumab (Keytruda), an immune checkpoint inhibitor, to standard chemotherapy before surgery could improve outcomes for patients with early-stage triple-negative breast cancer (TNBC). In this large phase 3 trial, 1,174 patients with stage II or III TNBC were randomly assigned
Cancer
What Are Current Prostate Cancer Treatments? Treating advanced prostate cancer often involves lowering the levels of male hormones (called androgens) in the body. This is because prostate cancer cells usually need these hormones to grow. One common treatment is called androgen deprivation therapy (ADT), which uses special medicines to stop
Cancer
What Did the Research Discover? Researchers conducted a phase 3 clinical trial to evaluate whether adding nivolumab, an immune therapy, to the standard chemotherapy drugs gemcitabine and cisplatin would improve survival for patients with advanced urothelial carcinoma (a type of bladder cancer). The study included 608 patients with unresectable or